| Dr Karis Bernhardt, MD | |
|
1776 E Robinson St, Norman, OK 73071-7442 | |
| (405) 360-5600 | |
| (405) 364-8432 |
| Full Name | Dr Karis Bernhardt |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 1776 E Robinson St, Norman, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174515977 | NPI | - | NPPES |
| 100102310A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 18198 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Karis Bernhardt, MD 1776 E Robinson, Norman, OK 73071-7442 Ph: (405) 360-5600 | Dr Karis Bernhardt, MD 1776 E Robinson St, Norman, OK 73071-7442 Ph: (405) 360-5600 |
News Archive
The European College of Neuropsychopharmacology (ECNP) is pleased to announce Kaj Blennow as the recipient of the 2010 ECNP Neuropsychopharmacology Award in recognition of his original and influential contributions to Alzheimer's disease research. The ECNP Neuropsychopharmacology Award is presented annually and recognises distinguished research in neuropsychopharmacology and closely related disciplines. The award is accompanied by a prize of - 20,000.
Elan Corporation plc and Celgene Corporation, today announced that Elan subsidiary Elan PharmaInternational Limited has entered into a settlement and license agreement with Celgene Corporation resolving the patent infringement litigation involving ABRAXANE.
Avila Therapeutics™, Inc., a biotechnology company developing targeted covalent drugs, announced today that it has initiated a phase 1 clinical trial to assess the safety, tolerability and pharmacokinetic profile of AVL-292, a novel, orally available, covalent drug that targets Bruton's tyrosine kinase (Btk). AVL-292 is the first product candidate to enter clinical evaluation from Avila's proprietary covalent drug platform, Avilomics™.
Selexis SA, a global life science company with technologies for drug discovery, cell line development and scale-up to manufacturing of therapeutic proteins announced today that CSL Limited has entered a commercial license agreement with Selexis for the preclinical development of a therapeutic antibody anticipated to enter Phase I clinical trials in 2012.
After a hepatitis vaccine was administered in their schools in central China, one child died and another 120 have become ill.
› Verified 3 days ago
Ms. Kathleen E Lewis, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1300 Mcgee Dr, Ste 100, Norman, OK 73072 Phone: 405-321-0406 Fax: 405-447-6293 | |
Jayson D Henry, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 500 E Robinson St, Suite 2200, Norman, OK 73071 Phone: 405-515-0380 Fax: 405-928-2054 | |
Dr. Hieu Chi Nguyen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 24th Ave Nw, Norman, OK 73069 Phone: 405-364-0555 Fax: 405-573-5464 | |
Kevin Q Epperson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3400 W Tecumseh Rd, Suite 104, Norman, OK 73072 Phone: 405-515-1800 Fax: 405-515-1805 | |
Bobby L Elliott, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 24th Ave Nw, Norman, OK 73069 Phone: 405-573-5400 Fax: 405-573-5406 | |
Dr. Aaron Michael Smathers, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3400 W Tecumseh Rd Ste 101, Norman, OK 73072 Phone: 405-515-0649 Fax: 405-360-6769 | |
Michelle Deann Barnes, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 950 N Porter Ave, Suite 300, Norman, OK 73071 Phone: 405-329-0121 Fax: 405-292-6099 |